Try our beta test site

Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Immunomedics, Inc.
Information provided by (Responsible Party):
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT01147393
First received: June 16, 2010
Last updated: February 7, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 31, 2017
  Primary Completion Date: August 6, 2013 (Final data collection date for primary outcome measure)